Lmr Partners LLP Galapagos Nv Transaction History

Lmr Partners LLP

$9.66 Billion
Q4 2024

A detailed history of Lmr Partners LLP transactions in Galapagos Nv stock. As of the latest transaction made, Lmr Partners LLP holds 10,768 shares of GLPG stock, worth $270,061. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,768

Previous 10,768 -0.0%

Holding current value

$270,061

Previous $310,000 4.52%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$36.5 - $48.0 $393,032 - $516,864	10,768 New	10,768 $416,000
Q2 2022 Aug 15, 2022	SELL	$52.3 - $71.59 $2.18 Million - $2.98 Million	-41,623 Reduced 83.67%	8,125 $453,000
Q1 2022 May 16, 2022	SELL	$51.32 - $68.5 $6.52 Million - $8.71 Million	-127,132 Reduced 71.87%	49,748 $3.09 Million
Q4 2021 Feb 14, 2022	BUY	$47.03 - $57.12 $3.62 Million - $4.39 Million	76,880 Added 76.88%	176,880 $9.75 Million
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $5.22 Million - $7.02 Million	100,000 New	100,000 $5.26 Million

Others Institutions Holding GLPG

# of Institutions

Shares Held

13.2M

Call Options Held

213K

Put Options Held

126K

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.65B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account